Synapse News
Fusion Pharmaceuticals to Build Radiopharmaceutical Manufacturing Facility at McMaster Innovation Park
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced it entered a 15-year lease agreement with Hamilton, Ontario-based McMaster University to build a 27,000 square foot current Good Manufacturing Practice (GMP) compliant…
POV Hamilton Podcast – Featuring Synapse Director Alex Muggah
The POV Hamilton podcast is exploring innovation in #HamOnt. We’re talking to movers, shakers, entrepreneurs, researchers, and more about what is making the Steel City such a hot spot for technology, innovation, growth, and discovery. Informative and unique points-of-view are waiting, explore Hamilton, Ontario with us! Join us as we…
NeRV – 2019 Synapse Competition Winner – raises $3.32M to bring tech to market
NeRV, a startup offering a sensory platform designed for the healthtech sector, has closed a $3.32 million CAD ($2.65 million USD) seed round of funding. NERv has been able to grow its team from 16 at the start of the pandemic to 24. The seed round was led by returning investor SOSV, with participation from […]
NERV Technology Raises $3.32M as it brings medical sensor tech to market
NERV Technology, an Innovation Factory client and Kitchener-Waterloo-based startup offering a sensory platform designed for the healthtech sector, has closed a $3.32 million CAD seed round of funding. NERv has developed a sensory device that is aimed to help doctors monitor postoperative patients remotely, by detecting potential…
Launchit: A new way of fostering health-tech companies
Launchit Ventures, a new healthtech venture studio, announced today the start of a new model of bringing innovations from idea to the commercialization. Launchit Ventures, as a venture studio, helps entrepreneurs build a team, obtain funding and necessary licenses, and will help arrange pilots and tests. “The venture studio model is…
ToeFX & Eye3 to join OBIO 2021 CAAP Cohort
The Ontario Bioscience Innovation Organization (OBIO) is proud to announce its 2021 Capital Access Advisory Program (CAAP) and the high-potential health science companies in this year’s cohort. CAAP 2021 logos. Hamilton-based ToeFx and Eye3 are set to join 6 other companies that make up the 2021 CAAP cohort. Now in its ninth year, OBIO CAAP…
Meet the Hamilton (Canadian) doctors working to identify and treat the rare blood clots linked to COVID-19 vaccines
A McMaster University lab that’s studied clots for decades has become key to the country’s efforts For decades, McMaster University in Hamilton, Ont., has been a hub for research on blood and its diseases — known as hematology — but in recent weeks it has taken on an even more prominent role in the field: […]
Opinion: The problem is pandemics and Canadian university research is the solution
Published in: Hill Times By: David Farrar, President and Vice-Chancellor, McMaster University For more than a year now, the world has been on a crisis footing after the emergence of a frightening new virus for which there was no known prevention, treatment, or cure. The pandemic’s ravages—including illness, death, economic upheaval, and…
Ottawa invests $6 million in the Innovation Factory
The federal government’s FedDev Ontario announced an investment of $6 million for Hamilton’s Innovation Factory, which will work alongside the Synapse Life Science Consortium to launch the Southern Ontario Pharmaceutical and Health Innovation Ecosystem (SOPHIE). SOPHIE will bring together Synapse’s network of experts in the life…